UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042598
Receipt number R000048604
Scientific Title Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.
Date of disclosure of the study information 2020/11/30
Last modified on 2021/08/03 10:52:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Acronym

Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Scientific Title

Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Scientific Title:Acronym

Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will clarify the current status of treatment with oral hypoglycemic agents for type 2 diabetes, as well as the perceptions, expectations, and needs of Physicians and patients regarding the administration of oral hypoglycemic agents.

Basic objectives2

Others

Basic objectives -Others

We will contribute to the realization of "patient-centered medical care" that respects the lifestyle, needs, values, and preferences of type 2 diabetic patients and the optimization of diabetes treatment.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Impact of Informed Choice on Physician-Patient Consciousness Gap on Weekly Oral Hypoglycemic Drugs.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

*Physicians: Physicians who treat an average of 5 or more type 2 diabetic patients a month
*Patients: Type 2 diabetic patients aged 20 years or older who regularly visit medical institutions for the treatment of type 2 diabetes and are prescribed oral hypoglycemic drugs.

Key exclusion criteria

Patients: Patients who are already taking the once upon a week oral hypoglycemic drug.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Kazunori
Middle name
Last name Aruse

Organization

QLife Co., Ltd.

Division name

CEO

Zip code

1050001

Address

4-3-9 Toranomon, Minato-ku, Tokyo

TEL

03-6860-5020

Email

sst@qlife.co.jp


Public contact

Name of contact person

1st name Yuriko
Middle name
Last name Kitahara

Organization

QLife Co., Ltd.

Division name

SST

Zip code

1050001

Address

4-3-9 Toranomon, Minato-ku, Tokyo

TEL

03-6860-5020

Homepage URL


Email

y-kitahara@qlife.co.jp


Sponsor or person

Institute

KISSEI PHARMACEUTICAL CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

KISSEI PHARMACEUTICAL CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical corporation Takahashi clinic clinical trial examination committee

Address

Medical Hat, 1st floor, 1-31, Iwayakitamachi, Nada-ku, Kobe-shi, Hyogo

Tel

03-43662-4504

Email

no-mori@mebix.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 30 Day


Related information

URL releasing protocol

http://lifescience.co.jp/yk/yk21/ykj2107.html

Publication of results

Published


Result

URL related to results and publications

http://lifescience.co.jp/yk/yk21/ykj2107.html

Number of participants that the trial has enrolled

1006

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 07 Month 30 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 11 Month 10 Day

Date of IRB

2020 Year 11 Month 17 Day

Anticipated trial start date

2020 Year 11 Month 27 Day

Last follow-up date

2020 Year 12 Month 28 Day

Date of closure to data entry

2020 Year 12 Month 28 Day

Date trial data considered complete

2021 Year 01 Month 13 Day

Date analysis concluded

2021 Year 03 Month 18 Day


Other

Other related information

*We conduct a web-based questionnaire survey from Novenber 27, 2020 to December 31, 2020 for patients with Type 2 diabetes in QLife members, etc.
*We conduct a web-based questionnaire survey from Novenber 27, 2020 to December 31, 2020 for diabetic Physicians with registered in Rakuten Insight.


Management information

Registered date

2020 Year 11 Month 30 Day

Last modified on

2021 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048604


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name